COVID-19 백신의 향후 사용에 대해 3개 다른 잠재적 시나리오가 예측됩니다. 1번째 시나리오에서는 COVID-19 백신의 연차 접종이 필요해질 것으로 상정되고, 2번째 시나리오에서는 65세 이상 하이리스크 집단으로의 매년 백신 접종, 3번째 시나리오에서는 65세 이상 하이리스크 집단으로의 격년 백신 접종이 상정되고 있습니다.
신종 코로나바이러스 감염증(COVID-19) 백신 시장에 대해 조사했으며, 이전(2021년 6월 발행한 Opportunity Assessment and Forecast to 2026)에서 다룬 COVID-19 백신의 환자 기반 판매 예측을 포함한 Excel 모델을 갱신·확장하고 있습니다.
예측 대상 : 주요 7개국 시장(미국, 프랑스, 독일, 이탈리아, 스페인, 영국, 일본)
예측기간 : 2021-2024년
조사 대상 범위
- 주요 요약
- 질환 개요 : 발생 경위, 병인, 병태생리
- 역학
- 현재 백신 선택사항 : SWOT 분석을 포함한 상세한 제품 프로파일
- 미충족 수요와 기회 : 중요한 KOL의 인사이트에 기반한 주요 미충족 수요 상세
- 파이프라인 평가 : 파이프라인 개요와 SWOT 분석을 포함한 상세한 제품 프로파일
- 연구개발 전략 : COVID-19 백신 임상시험 설계와 거래 결정 동향
- 시장 전망
KSM 22.02.08
This publication is an update and extension to the Excel model containing the patient-based sales forecast for COVID-19 vaccines, which was previously covered in Coronavirus Disease 2019 (COVID 19) Vaccines: Opportunity Assessment and Forecast to 2026, published in June 2021.
Report deliverables include a PowerPoint report and an interactive Excel-based forecast model
Forecasts includes 7MM (US, France, Germany, Italy, Spain, UK, and Japan)
Forecasts cover 5 years from 2021 to 2026
GlobalData forecast three different potential scenarios for the future use of COVID-19 vaccines -
- The first scenario assumes that annual vaccination with a COVID-19 vaccine will be needed.
- The second scenario assumes annual vaccination for the high-risk population of people 65 years of age and older, while everyone below 65 years of age will need a vaccine only every two years.
- In the third scenario, the high-risk population of people 65 years of age and older will receive a COVID-19 vaccine every two years, while everyone below 65 years will need a vaccine only every five years.
Scope
This report includes -
- Executive Summary
- Disease Overview: History of the outbreak, Etiology and Pathophysiology
- Epidemiology
- Current Vaccination Options: Includes detailed product profiles with SWOT analysis
- Unmet Need and Opportunities: Detailing the major unmet needs with significant KOL insights
- Pipeline Assessment: Includes pipeline overview and detailed product profiles with SWOT analysis
- R&D Strategies: Trends in Clinical Trial Design for COVID-19 Vaccines and Trends in Deal-Making
- Market Outlook
Reasons to Buy
- To understand the current COVID-19 vaccine situation in multiple regions.
- Develop business strategies by understanding the trends shaping and driving the 7MM COVID-19 vaccine.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global COVID-19 vaccine market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
